Buy Lipo-C LC216 Online

Product Details: Lipo-C LC216

What is Lipo-C LC216?

Lipo-C LC216 is an eight-compound research formulation. It combines eight distinct nutrient compounds in a single 10ml solution. Each vial delivers L-Carnitine 20mg, L-Arginine 20mg, Methionine 25mg, Inositol 50mg, Choline 50mg, Vitamin B6 25mg, Vitamin B5 25mg, and Vitamin B12 1mg. Total delivery is 216mg per 10ml vial.

L-Carnitine is a mitochondrial fatty-acid transport compound. L-Arginine is a nitric-oxide precursor amino acid. Methionine, Inositol, and Choline are classic lipotropic research compounds studied for liver fat metabolism. Vitamins B6, B5, and B12 are water-soluble coenzyme-precursor vitamins. In preclinical models, these compounds are studied to assess their influence on cellular signaling pathways involved in:

• Mitochondrial fatty-acid transport and energy metabolism
• Nitric-oxide-mediated blood-flow signaling
• Hepatic lipid transport, and
• Coenzyme-dependent methylation and amino-acid metabolism

This liquid solution format is used in research settings as a delivery method that allows investigators to study combined nutrient uptake and metabolism without preparing and mixing eight separate compounds.

Disclaimer: Lipo-C LC216 is a research compound not approved by the U.S. Food and Drug Administration (FDA) for human or veterinary use as this co-blended formulation. It is not intended to diagnose, treat, cure, or prevent any disease. This product is strictly for laboratory research purposes only.

ATTENTION: This product is strictly for LABORATORY AND RESEARCH PURPOSES ONLY. Not for human or veterinary use.

Mechanism of Action of Lipo-C LC216

L-Carnitine and L-Arginine Working in Preclinical Models

L-Carnitine is thought to work primarily through transport of long-chain fatty acids across the mitochondrial membrane, a rate-limiting step in fatty-acid oxidation research. L-Arginine is thought to work as a nitric-oxide precursor, relevant to blood-flow and vascular-signaling research.

Key mechanistic observations from laboratory studies:

• Fatty-acid transport: L-Carnitine is thought to shuttle fatty acids into the mitochondrial matrix for beta-oxidation.
• Nitric-oxide precursor activity: L-Arginine is thought to support nitric-oxide synthesis, relevant to vascular-tone research.

Methionine, Inositol, and Choline Working in Preclinical Models

Methionine, Inositol, and Choline are thought to work together as classic lipotropic agents, supporting hepatic lipid transport and phospholipid synthesis. This is thought to affect liver fat accumulation research in experimental models.

Key mechanistic observations from laboratory studies:

• Methyl-donor activity: Methionine is thought to support methylation reactions relevant to lipid metabolism research.
• Phospholipid synthesis: Choline is thought to support phosphatidylcholine synthesis, relevant to hepatic lipid-transport research.
• Cell-signaling modulation: Inositol has been observed influencing cell-signaling markers in preclinical research models.

Vitamin B6, B5, and B12 Working in Preclinical Models

Vitamins B6, B5, and B12 are thought to act as coenzyme or coenzyme-precursor components involved in amino-acid, fatty-acid, and methylation metabolism pathways. In this formulation, Vitamin B5 is delivered as calcium pantothenate, a stable salt form that provides free pantothenic acid in solution.

Key mechanistic observations from laboratory studies:

• Coenzyme A synthesis: Vitamin B5, delivered here as calcium pantothenate (which provides pantothenic acid in solution), is thought to support coenzyme A synthesis, relevant to fatty-acid metabolism research.
• Amino-acid metabolism: Vitamin B6 (pyridoxine) is thought to support amino-acid and neurotransmitter metabolism research.
• Methylation-cycle support: Vitamin B12 (cyanocobalamin) is thought to support methionine synthase coenzyme activity relevant to methylation research.

Chemical Properties of Lipo-C LC216

L-Carnitine

L-Arginine

Methionine

Inositol

Choline

Vitamin B6

Vitamin B5

Vitamin B12

Blend Specification

Research Applications of Lipo-C LC216

1. Fatty-Acid Transport and Vascular Signaling Research L-Carnitine's mitochondrial fatty-acid transport role, paired with L-Arginine's nitric-oxide precursor activity, makes this blend a tool for investigating combined energy-metabolism and blood-flow signaling research.
2. Hepatic Lipid Metabolism Research Methionine, Inositol, and Choline's classic lipotropic pairing supports research into liver fat transport and phospholipid synthesis in metabolic research models.
3. Coenzyme and Methylation Pathway Research Vitamins B6, B5, and B12 support research into coenzyme A synthesis, amino-acid metabolism, and methylation-cycle activity.
4. Combination Nutrient-Pathway Research Because these eight compounds span energy metabolism, vascular signaling, hepatic lipid transport, and coenzyme pathways, researchers use this blend to study combined nutrient-metabolism effects across multiple systems.

Risk and Handling Precautions

Risk Tier: LOW

This rating reflects all eight compounds' long-established safety history as nutritional and biochemical research substances, several of which are recognized by NIH's Office of Dietary Supplements, while noting that this specific eight-compound co-blended research solution has not itself been evaluated by the FDA. Researchers must observe the following precautions at all times.

Handling Precautions: Lipo-C LC216 should be handled by trained laboratory personnel only. Use appropriate personal protective equipment (PPE) at all times, including gloves and eye protection. Avoid direct skin contact, inhalation, or accidental exposure during laboratory handling.

Exposure Risks: All eight compounds have a long safety history as nutritional research substances, though no formal human exposure data exists specific to this exact eight-compound co-blended solution.

Storage: Store at 2–8°C in a dry, dark environment protected from light and moisture. Do not freeze. This product is supplied as a ready-to-use aqueous solution — no reconstitution is required. Check the batch Certificate of Analysis for lot-specific guidance. Do not use if the seal has been compromised.

Toxicity and Data Limitations: No chronic toxicity data exist for this specific blend ratio. Individual-compound safety data comes from nutrition and biochemical research recognized by NIH, but findings cannot be assumed to apply directly to this co-blended vendor formulation.

Why Choose BehemothLabz for Research-Grade Lipo-C LC216?

BehemothLabz supplies Lipo-C LC216 for laboratory and research purposes. Every batch is independently tested by third-party laboratories for purity and identity. A Certificate of Analysis is publicly available for each lot. BehemothLabz does not self-certify.

The compound is USA-made and held to research-grade standards. It is available strictly to qualified researchers for use in controlled laboratory environments.

BehemothLabz Disclaimer

ATTENTION: All BehemothLabz products are strictly for LABORATORY AND RESEARCH PURPOSES ONLY. They are not to be used for any human or veterinary purposes.

Please make sure you go through the Terms and Conditions and familiarize yourself with them, as it is important. Kindly research the scientific uses of this product before making any purchases. Make note that the packaging and labels of the product may differ from those shown on the website.

Buying the product means you agree to our Terms and Conditions. You can contact our customer service team at support@behemothlabz.com if you are not fully satisfied with the product.

Lipo-C LC216 Research FAQs

Is any compound in this blend banned by WADA? 

No. None of the eight compounds — L-Carnitine, L-Arginine, Methionine, Inositol, Choline, Vitamin B6, Vitamin B5, or Vitamin B12 — appear on the World Anti-Doping Agency's Prohibited List. This is directly checkable at wada-ama.org/en/prohibited-list; none of these fall under any S-category covered by that list.

Is any compound in this blend FDA-approved? 

Two of the eight, in specific, separate forms unrelated to this blend. Levocarnitine is FDA-approved as the prescription drug Carnitor, and cyanocobalamin injection is separately FDA-approved as a prescription B12 injectable — both verifiable via the FDA's DailyMed database at dailymed.nlm.nih.gov. Neither approval applies to this eight-compound research-grade blend, which is not FDA-approved as sold.

Does the NIH recognize these as real nutrients? 

Yes, for most of them. L-Arginine, Methionine, Choline, Vitamin B6, and Vitamin B5 each have recognized nutritional roles documented by the NIH's Office of Dietary Supplements (ods.od.nih.gov). Vitamin B12 (cyanocobalamin) is documented in the same database's B12 fact sheet. Carnitine and Inositol are documented in NIH-affiliated literature, though not always under a dedicated standalone ODS fact sheet.

How does LC216 differ from LC120? 

LC216 is an 8-component expanded lipotropic blend. LC120 is the 4-component foundational blend (methionine, choline chloride, carnitine, dexpanthenol). LC216 adds L-arginine (NOS/NO research), inositol (PI cascade research), vitamin B6, and vitamin B12 (one-carbon/methylation research) on top of that foundation. Choose LC120 for isolated CPT-1/lipotropic research; LC216 for broader metabolic pathway coverage spanning vascular and methylation signaling as well.

Would this require a compounding pharmacy prescription for human use? 

Injectable multi-component nutrient blends intended for human administration require compounding pharmacy prescriptions in the USA. This research-grade formulation is not a compounded pharmaceutical product and is not dispensed or labeled for human administration.

Can I verify the chemical identity of each compound independently? 

Yes. Each compound has a public PubChem entry maintained by NCBI (part of NIH): L-Carnitine (CID 288), L-Arginine (CID 6322), Methionine (CID 6137), Inositol (CID 892), Choline bitartrate (CID 10198924), Vitamin B6 / pyridoxine HCl (CID 6019), Vitamin B5 / calcium pantothenate (CID 443753), and Vitamin B12 / cyanocobalamin (CID 16212801). These can be checked directly at pubchem.ncbi.nlm.nih.gov.

What does each vial deliver? 

Each 10ml vial delivers L-Carnitine 20mg, L-Arginine 20mg, Methionine 25mg, Inositol 50mg, Choline 50mg, Vitamin B6 25mg, Vitamin B5 25mg, and Vitamin B12 1mg, totaling 216mg.

Is this blend approved for human use? 

No. This eight-compound co-blended formulation has not been evaluated or approved by the FDA. This product is for laboratory research only.

What purity standard does BehemothLabz provide for this blend? 

Every batch is independently tested by third-party laboratories. All eight compounds are verified at ≥99% purity by HPLC analysis. A Certificate of Analysis confirming purity and molecular identity is available per lot.

How should Lipo-C LC216 be stored? 

Store at 2–8°C in a dry, dark environment protected from light and moisture. Do not freeze. Check the batch Certificate of Analysis for lot-specific guidance. Do not use it if the seal has been compromised.

References

1. National Center for Biotechnology Information (NCBI). PubChem entries for L-Carnitine (CID 288), L-Arginine (CID 6322), Methionine (CID 6137), Inositol (CID 892), Choline bitartrate (CID 10198924), Vitamin B6 / pyridoxine HCl (CID 6019), Vitamin B5 / calcium pantothenate (CID 443753), and Vitamin B12 / cyanocobalamin (CID 16212801). National Institutes of Health. https://pubchem.ncbi.nlm.nih.gov
2. National Institutes of Health, Office of Dietary Supplements. Choline – Health Professional Fact Sheet; Vitamin B6 – Health Professional Fact Sheet; Vitamin B12 – Health Professional Fact Sheet. https://ods.od.nih.gov/factsheets/list-all/
3. U.S. Food and Drug Administration / DailyMed. Carnitor (levocarnitine) and Cyanocobalamin Injection, USP — Drug Labels. https://dailymed.nlm.nih.gov
4. World Anti-Doping Agency. The 2026 Prohibited List International Standard (confirms none of the eight compounds in this blend are listed). https://www.wada-ama.org/en/prohibited-list

Please click here to access instructions on how to make a payment.